370 related articles for article (PubMed ID: 34243793)
1. Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning.
Yuen SC; Liang X; Zhu H; Jia Y; Leung SW
Alzheimers Res Ther; 2021 Jul; 13(1):126. PubMed ID: 34243793
[TBL] [Abstract][Full Text] [Related]
2. Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer's Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling.
Yuen SC; Lee SM; Leung SW
J Alzheimers Dis; 2022; 85(3):1373-1398. PubMed ID: 34924393
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of miRNA and mRNA expression in the blood of patients with Alzheimer's disease.
Wang Z; Shen L; Wang Y; Huang S
Mol Med Rep; 2020 Aug; 22(2):1053-1062. PubMed ID: 32468026
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease.
Li H; Zou L; Shi J; Han X
Hereditas; 2021 Jul; 158(1):25. PubMed ID: 34243818
[TBL] [Abstract][Full Text] [Related]
5. Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.
Li J; Xu C; Zhang J; Jin C; Shi X; Zhang C; Jia S; Xu J; Gui X; Xing L; Lu L; Xu L
Neurochem Res; 2021 Apr; 46(4):964-979. PubMed ID: 33586092
[TBL] [Abstract][Full Text] [Related]
6. The role of microRNAs in understanding sex-based differences in Alzheimer's disease.
Llera-Oyola J; Carceller H; Andreu Z; Hidalgo MR; Soler-Sáez I; Gordillo F; Gómez-Cabañes B; Roson B; de la Iglesia-Vayá M; Mancuso R; Guerini FR; Mizokami A; García-García F
Biol Sex Differ; 2024 Jan; 15(1):13. PubMed ID: 38297404
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease.
Chang WS; Wang YH; Zhu XT; Wu CJ
Med Sci Monit; 2017 Jun; 23():2721-2731. PubMed ID: 28578378
[TBL] [Abstract][Full Text] [Related]
8. An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma.
Liu L; Wang H; Yan C; Tao S
Technol Cancer Res Treat; 2020; 19():1533033820956998. PubMed ID: 32985354
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.
Xu A; Kouznetsova VL; Tsigelny IF
J Alzheimers Dis; 2022; 86(2):841-859. PubMed ID: 35147545
[TBL] [Abstract][Full Text] [Related]
10. The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.
Pang X; Zhao Y; Wang J; Zhou Q; Xu L; Kang D; Liu AL; Du GH
Biomed Res Int; 2017; 2017():9084507. PubMed ID: 29359159
[TBL] [Abstract][Full Text] [Related]
11. miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach.
Pereira JD; Teixeira LCR; Mamede I; Alves MT; Caramelli P; Luizon MR; Veloso AA; Gomes KB
J Neurochem; 2024 Jun; 168(6):977-994. PubMed ID: 38390627
[TBL] [Abstract][Full Text] [Related]
12. An integrative machine-learning meta-analysis of high-throughput omics data identifies age-specific hallmarks of Alzheimer's disease.
Shokhirev MN; Johnson AA
Ageing Res Rev; 2022 Nov; 81():101721. PubMed ID: 36029998
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of transcriptomics data identifies potential biomarkers and their associated regulatory networks in gallbladder cancer.
Singh N; Sharma R; Bose S
Gastroenterol Hepatol Bed Bench; 2022; 15(4):311-325. PubMed ID: 36762219
[TBL] [Abstract][Full Text] [Related]
14. Adaptive boosting-based computational model for predicting potential miRNA-disease associations.
Zhao Y; Chen X; Yin J
Bioinformatics; 2019 Nov; 35(22):4730-4738. PubMed ID: 31038664
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic Analysis and Experimental Validation of Ubiquitin-Proteasomal System-Related Hub Genes as Novel Biomarkers for Alzheimer's Disease.
Zhang Y; Wu J; You G; Guo W; Wang Y; Yu Z; Geng Y; Zhong Q; Zan J; Zheng L
J Integr Neurosci; 2023 Oct; 22(6):138. PubMed ID: 38176925
[TBL] [Abstract][Full Text] [Related]
16. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
He H; Liu A; Zhang W; Yang H; Zhang M; Xu H; Liu Y; Hong B; Yan F; Yue L; Wang J; Xiao S; Xie Z; Wang T
J Alzheimers Dis; 2021; 83(2):779-790. PubMed ID: 34366343
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Diagnostic miRNAs Biomarkers for Alzheimer Disease Based on Weighted Gene Coexpression Network Analysis.
Lin F; Zhang H; Bao J; Li L
World Neurosurg; 2021 Sep; 153():e315-e328. PubMed ID: 34224891
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm.
Ji W; An K; Wang C; Wang S
Hereditas; 2022 Oct; 159(1):38. PubMed ID: 36195955
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA biomarkers of type 2 diabetes: evidence synthesis from meta-analyses and pathway modelling.
Zhu H; Leung SW
Diabetologia; 2023 Feb; 66(2):288-299. PubMed ID: 36269347
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Expression Profiles Identify Biomarker for Differentiating the Embolic Stroke from Thrombotic Stroke.
Chen LT; Jiang CY
Biomed Res Int; 2018; 2018():4514178. PubMed ID: 30627556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
